Strides Pharma Science submits press release

04 Dec 2019 Evaluate

Strides Pharma Science has informed about submission of Press Release issued by the Company titled: ‘Strides receives USFDA tentative approval for Diclofenac Potassium Softgel Capsules’.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

876.70 -23.95 (-2.66%)
19-Jan-2026 12:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.60
Dr. Reddys Lab 1171.55
Cipla 1391.80
Zydus Lifesciences 865.50
Lupin 2185.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×